Extreme Medicine

ORIGINAL RESEARCH

Features of using a lymphocyte test for biological dosimetry in the early period after exposure

Sedankin MK, Gudkov EA, Soloviev VYu, Mershin LYu

Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency, Moscow, Russia

Correspondence should be addressed: Mikhail K. Sedankin
Zhivopisnaya, 46, Moscow, 123098, Russia; ur.xednay@niknadesm

About paper

Author contribution: Sedankin MK — study concept and design, manuscript writing, literature review, approval of the final version of the article; Gudkov EA — study concept and design, data acquisition, data interpretation, computation tool development; Soloviev VYu — general management, study concept and design, manuscript writing; Mershin LYu — editing, data interpretation, computation tool optimization.

Received: 2023-08-10 Accepted: 2023-09-11 Published online: 2023-09-28

No data available...

Link to the next paper will be sent to the indicated e-mail's:

ORIGINAL RESEARCH Features of using a lymphocyte test for biological dosimetry in the early period after exposure

Sedankin MK, Gudkov EA, Soloviev VYu, Mershin LYu

Published in "Bulletin of RSMU" 3, 2023

I want to receive a copy of this message

Vancouver style

Sedankin MK, Gudkov EA, Soloviev VY, Mershin LY. Features of using a lymphocyte test for biological dosimetry in the early period after exposure. Extreme Medicine. 2023; (3): 61–5. DOI: 10.47183/mes.2023.034

Harvard style

Sedankin, M. K., Gudkov, E. A., Soloviev, V. Y. and Mershin, L. Y. (2023), "Features of using a lymphocyte test for biological dosimetry in the early period after exposure", Extreme Medicine, no. 3, p. 61–65. DOI: 10.47183/mes.2023.034

Remember me

Forgot password?

I accept Editorial Policies of the journal

Archive

2023 / 03

ORIGINAL RESEARCH

Features of using a lymphocyte test for biological dosimetry in the early period after exposure